GlassScriptPhysician profile
Amanda L Cox
NPI 1801173604
$8,328.50
in general payments reported to CMS, 2019-2025
38 companies · $1,659 in 2025
The $1,659 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,723 · 2022: $1,813 · 2023: $1,901 · 2024: $1,234 · 2025: $1,659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,792.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,059.12 | 2021-2025 | |
| Novo Nordisk INC | $1,054.06 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $858.78 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $334.58 | 2021-2025 | |
| Tactile Systems Technology INC | $316.03 | 2021-2024 | Flexitouch Plus, Entre Plus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $313.44 | 2021-2025 | Jardiance |
| Lilly USA, LLC | $311.37 | 2021-2025 | Mounjaro, Emgality, Zepbound |
| Exact Sciences Corporation | $295.34 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $271.84 | 2021-2024 | Xifaxan, Trulance |
| Janssen Pharmaceuticals, INC | $248.85 | 2021-2025 | Spravato, Xarelto |
| Astrazeneca Pharmaceuticals LP | $245.64 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Abbott Laboratories | $232.94 | 2022-2025 | Freestyle Libre 3 |
| E.R. Squibb & Sons, L.L.C. | $232.66 | 2021-2025 | Eliquis, Camzyos |
| Merck Sharp & Dohme LLC | $194.52 | 2021-2024 | Vaxelis, Gardasil 9, M-M-R II |
| Amgen INC. | $158.53 | 2021-2023 | Prolia, Repatha, Evenity |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.